Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 EUR | +0.53% | +2.17% | +6.82% |
Chart calendar Knight Therapeutics Inc.
Upcoming events on Knight Therapeutics Inc.
Past events on Knight Therapeutics Inc.
2024-05-14 03:05 pm | RBC Capital Markets Global Healthcare Conference - Fireside Chat |
2024-05-09 08:30 am | Q1 2024 Earnings Call |
2024-05-09 07:30 am | Q1 2024 Earnings Release |
2024-05-08 10:00 am | Annual General Meeting |
2024-04-16 10:30 am | Bloom Burton & Co. Healthcare Investor Conference |
2024-03-21 08:30 am | Q4 2023 Earnings Call |
2024-03-21 07:30 am | Q4 2023 Earnings Release |
2023-11-09 09:52 am | Q3 2023 Earnings Release |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-08-10 08:30 am | Q2 2023 Earnings Call |
2023-08-10 07:30 am | Q2 2023 Earnings Release |
2023-06-09 09:00 am | Jefferies Global Healthcare Conference |
2023-05-16 10:30 am | RBC Global Healthcare Conference |
2023-05-11 08:30 am | Q1 2023 Earnings Call |
2023-05-11 07:30 am | Q1 2023 Earnings Release |
2023-05-10 09:00 am | Annual General Meeting |
2023-04-25 01:30 pm | Bloom Burton & Co Healthcare Investor Conference |
2023-03-23 08:30 am | Q4 2022 Earnings Call |
2023-03-23 07:30 am | Q4 2022 Earnings Release |
2022-11-15 01:15 pm | Stifel Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 47,5 41,9 13.33% | 200 192 3.65% | 243 247 -1.56% | 294 275 6.89% | 328 333 -1.35% | 346 |
EBITDA Million CAD | Released Forecast Spread | -9,24 -11,0 15.87% | 16,8 16,4 2.85% | 38,0 43,0 -11.62% | 54,0 45,9 17.82% | 60,1 60,2 -0.17% | 58,2 |
EBIT Million CAD | Released Forecast Spread | 0,00 0,00 - | -4,47 0,89 -601.12% | 28,3 35,7 -20.61% | 34,7 25,6 35.43% | 51,4 51,8 -0.79% | 54,2 |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 22,8 33,2 -31.29% | 32,1 24,7 29.97% | 6,69 20,9 -67.97% | -44,0 -32,1 -37.01% | -22,0 1,62 -1460.48% | -3,52 |
Net income Million CAD | Released Forecast Spread | 14,5 27,1 -46.35% | 42,1 30,9 36.22% | 15,7 23,8 -34.17% | -29,9 -22,5 -32.6% | -16,8 5,83 -388.8% | 2,49 |
EPS CAD | Released Forecast Spread | 0,10 0,19 -45.95% | 0,32 0,24 34.79% | 0,13 0,20 -35% | -0,26 -0,19 -36.84% | -0,16 0,06 -374.3% | 0,03 |
Announcement Date | 30/03/20 | 25/03/21 | 24/03/22 | 23/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 63,8 56,4 13.16% | 75,8 64,9 16.91% | 72,3 63,9 13.08% | 81,7 61,3 33.13% | 82,6 75,0 10.16% | 89,9 80,7 11.37% | 81,5 73,5 10.87% | 74,2 78,7 -5.69% | 86,6 79,5 8.94% | 87,7 | 86,7 | 84,9 | 87,3 | 90,5 |
EBITDA Million CAD | Released Forecast Spread | 13,3 6,98 90.85% | 17,9 10,5 70.97% | 9,01 8,23 9.43% | 13,8 5,27 162.42% | 18,2 12,5 45.72% | 14,3 13,5 5.74% | 15,5 10,1 53.43% | 12,1 12,8 -5.56% | 13,6 13,7 -0.64% | 14,7 | 15,1 | 14,3 | 15,1 | 15,6 |
EBIT Million CAD | Released Forecast Spread | 11,0 2,37 362.17% | 13,4 6,78 97.62% | 2,31 2,19 5.58% | 8,01 -1,06 852.82% | 16,8 8,08 107.92% | 11,2 17,1 -34.72% | 12,4 9,91 25.26% | 11,0 11,4 -3.56% | 13,5 14,6 -7.38% | 10,8 | 14,7 | 15,2 | ||
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -22,3 -7,07 -215.54% | 0,64 -5,39 111.81% | 0,85 -8,12 110.48% | -23,1 -11,3 -105.29% | -4,95 -6,79 27.17% | 0,21 -2,77 107.65% | 8,90 -4,91 281.34% | -26,2 -2,54 -928.72% | -7,14 1,29 -653.37% | 0,65 | 1,35 | 1,83 | 1,00 | 1,80 |
Net income Million CAD | Released Forecast Spread | -18,8 -4,95 -279.83% | 2,52 -2,45 202.65% | 1,59 -4,36 136.5% | -15,2 -6,01 -152.75% | -3,94 -5,78 31.84% | 1,84 -0,81 328% | 9,59 -2,91 429.88% | -24,3 -1,67 -1359.92% | -4,55 0,93 -589.08% | 0,72 | 1,41 | 1,46 | 0,80 | 1,40 |
EPS CAD | Released Forecast Spread | -0,16 -0,04 -300% | 0,02 -0,03 176.92% | 0,01 -0,04 127.78% | -0,13 -0,06 -116.67% | -0,04 -0,06 36.84% | 0,02 -0,01 260% | 0,09 -0,04 307.71% | -0,23 -0,01 -1870.87% | -0,04 0,00 -1700% | 0,02 | 0,02 | 0,03 | 0,01 | 0,01 |
Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Knight Therapeutics Inc.
2024-05-23 01:00 am | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
2024-05-15 01:00 am | MERCK KGAA: Q1 2024 Earnings Release |
2024-05-13 | OSCOTEC INC.: Q1 2024 Earnings Release |
2024-05-13 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release |
2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GUD Stock
- 04K Stock
- Calendar Knight Therapeutics Inc.